Cantourage Group SE (ETR:HIGH)
5.18
-0.02 (-0.38%)
At close: Oct 6, 2026
Cantourage Group SE Market Cap
Cantourage Group SE has a market cap or net worth of €64.84 million as of October 6, 2026. Its market cap has increased by 42.47% in one year.
Market Cap
64.84M
Enterprise Value
64.70M
Revenue
3.91M
Ranking
n/a
PE Ratio
512.77
Stock Price
€5.18
ChartMarket Cap Chart
Since November 11, 2022, Cantourage Group SE's market cap has decreased from 193.56M to 64.84M, a decrease of -66.50%. That is a compound annual growth rate of -24.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 64.84M | 53.39% |
| Dec 30, 2025 | 42.27M | -33.53% |
| Dec 30, 2024 | 63.60M | -25.41% |
| Dec 29, 2023 | 85.26M | -49.22% |
| Dec 30, 2022 | 167.91M | -13.25% |
| Nov 11, 2022 | 193.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.52B |
| Bayer Aktiengesellschaft | 44.15B |
| Siemens Healthineers AG | 42.14B |
| Fresenius SE & Co. KGaA | 24.58B |
| LIMES Schlosskliniken AG | 171.32M |
| Viromed Medical AG | 123.25M |
| Heidelberg Pharma AG | 109.94M |
| DocCheck AG | 54.29M |